Maravai LifeSciences Holdings, Inc. (MRVI)
USD 2.07
(-1.43%)
USD 2.07
(-1.43%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 140.2 Million USD | -80.73% |
| 2022 | 714.04 Million USD | 8.41% |
| 2021 | 658.67 Million USD | 222.17% |
| 2020 | 204.44 Million USD | 167.99% |
| 2019 | 76.29 Million USD | 20.97% |
| 2018 | 63.06 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 18.97 Million USD | -50.63% |
| 2024 Q2 | 28.26 Million USD | 85.13% |
| 2023 Q4 | 38.43 Million USD | 27.35% |
| 2023 FY | 137.6 Million USD | -80.73% |
| 2023 Q1 | 45.34 Million USD | -70.06% |
| 2023 Q3 | 30.17 Million USD | 17.7% |
| 2023 Q2 | 25.64 Million USD | -43.46% |
| 2022 Q4 | 151.46 Million USD | -1.06% |
| 2022 Q3 | 153.08 Million USD | -25.41% |
| 2022 Q2 | 205.23 Million USD | 0.48% |
| 2022 Q1 | 204.26 Million USD | 7.9% |
| 2022 FY | 714.04 Million USD | 8.41% |
| 2021 Q4 | 189.3 Million USD | 9.58% |
| 2021 FY | 658.67 Million USD | 222.17% |
| 2021 Q3 | 172.76 Million USD | -4.16% |
| 2021 Q2 | 180.26 Million USD | 52.97% |
| 2021 Q1 | 117.84 Million USD | 57.21% |
| 2020 Q1 | 35.68 Million USD | 96.82% |
| 2020 Q3 | 68.09 Million USD | 164.89% |
| 2020 Q2 | 25.7 Million USD | -27.96% |
| 2020 FY | 204.44 Million USD | 167.99% |
| 2020 Q4 | 74.95 Million USD | 10.07% |
| 2019 Q4 | 18.13 Million USD | 0.0% |
| 2019 FY | 76.29 Million USD | 20.97% |
| 2018 FY | 63.06 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -565.695% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 60531.897% |
| Vaxxinity, Inc. | -2.23 Million USD | 6375.828% |
| IO Biotech, Inc. | -756 Thousand USD | 18645.238% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -599.192% |
| MEI Pharma, Inc. | 49.32 Million USD | -184.23% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 225.839% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -27123.689% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 1168450.0% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 21214.759% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 3656.578% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -48.013% |
| Agenus Inc. | 139.61 Million USD | -0.42% |
| AlloVir, Inc. | -398 Thousand USD | 35326.633% |
| CRISPR Therapeutics AG | 240.95 Million USD | 41.814% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -3.647% |
| NextCure, Inc. | -3.68 Million USD | 3905.7% |
| Opthea Limited | 21.72 Thousand USD | -645397.238% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 317385.236% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -27.721% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -550.74% |
| Senti Biosciences, Inc. | -2.68 Million USD | 5325.568% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -16.375% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 276414.545% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 90.763% |
| BioLineRx Ltd. | 1.1 Million USD | -12553.61% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 7518.095% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -17381.546% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 24653.765% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 399.327% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -3102.421% |
| AbCellera Biologics Inc. | 38.02 Million USD | -268.71% |
| ADMA Biologics, Inc. | 88.21 Million USD | -58.927% |
| Aptorum Group Limited | -1.11 Million USD | 12677.69% |
| AnaptysBio, Inc. | 14.78 Million USD | -848.529% |
| Ardelyx, Inc. | 106.66 Million USD | -31.446% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 41.761% |
| Bicycle Therapeutics plc | -129.52 Million USD | 208.247% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -116735.0% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 244.613% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -1681.248% |
| Chimerix, Inc. | 324 Thousand USD | -43172.222% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 549.832% |
| Dyadic International, Inc. | 922.95 Thousand USD | -15090.524% |
| Elevation Oncology, Inc. | -39 Thousand USD | 359592.308% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 118422.911% |
| Fortress Biotech, Inc. | 57.85 Million USD | -142.342% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 242.826% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 97937.419% |
| Fortress Biotech, Inc. | 57.85 Million USD | -142.342% |
| ChromaDex Corporation | 50.78 Million USD | -176.097% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 3897.454% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 280.677% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 232.113% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -22921.675% |
| Incyte Corporation | 3.44 Billion USD | 95.925% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 5348.008% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 95475.51% |
| Jaguar Health, Inc. | 7.72 Million USD | -1715.148% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 95.875% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 255012.727% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -17.076% |
| ContextLogic Inc. | 59 Million USD | -137.631% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 80287.368% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 26703.795% |
| MiMedx Group, Inc. | 266.84 Million USD | 47.459% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -382.54% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 14870.948% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -745.762% |
| Onconetix, Inc. | -1.12 Million USD | 12538.463% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 583.989% |
| Psyence Biomedical Ltd. | -240.00 USD | 58417600.0% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 244669.654% |
| Precigen, Inc. | 106 Thousand USD | -132166.038% |
| Pharming Group N.V. | 220.1 Million USD | 36.302% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -13795.144% |
| PureTech Health plc | -1.6 Million USD | 8846.226% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 4048.24% |
| Royalty Pharma plc | 1.79 Billion USD | 92.185% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Seer, Inc. | 7.02 Million USD | -1895.19% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 409.326% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 737.659% |
| Acelyrin, Inc. | -115 Thousand USD | 122014.783% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 1395005.98% |
| Pyxis Oncology, Inc. | -2 Million USD | 7110.1% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 27231.705% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 242.747% |
| TG Therapeutics, Inc. | 219.1 Million USD | 36.012% |
| Alkermes plc | 1.37 Billion USD | 89.801% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -381.314% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 8208.849% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -5346.853% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -636.239% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -28166.532% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -34.681% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 177.285% |
| Geron Corporation | -123.5 Million USD | 213.521% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 171078.049% |
| Summit Therapeutics Inc. | -2.05 Million USD | 6939.122% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -3360.923% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 3022.093% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 1149.585% |
| Innoviva, Inc. | 261.06 Million USD | 46.296% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 2804140.0% |
| Vaxcyte, Inc. | -75 Million USD | 286.936% |
| Molecular Templates, Inc. | 50.39 Million USD | -178.206% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -32966.509% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -377.089% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 28596.341% |
| Novavax, Inc. | 639.93 Million USD | 78.091% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 711.728% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 55.303% |
| Precision BioSciences, Inc. | 40.47 Million USD | -246.417% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| ImmuCell Corporation | 4.39 Million USD | -3089.102% |
| Immix Biopharma, Inc. | -5468.00 USD | 2564145.355% |
| Mesoblast Limited | -9.81 Million USD | 1528.446% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 2075.232% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 29644.511% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 1348196.154% |
| Soligenix, Inc. | 97.31 Thousand USD | -143976.209% |
| Century Therapeutics, Inc. | -10.8 Million USD | 1397.086% |
| Kura Oncology, Inc. | -849 Thousand USD | 16613.781% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 308.932% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -41.562% |
| Autolus Therapeutics plc | -4.86 Million USD | 2980.666% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -238.767% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 83553.571% |
| GRI Bio, Inc. | 10.84 Million USD | -1193.257% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -5419.794% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 1713.929% |
| IGM Biosciences, Inc. | -211.66 Million USD | 166.239% |
| INmune Bio, Inc. | 155 Thousand USD | -90352.903% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -126.355% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 9407.763% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 21720.963% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 479030.109% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -34776.119% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 7124.148% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 44892.971% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -48.423% |
| Verastem, Inc. | -62 Thousand USD | 226232.258% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -5657.782% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 53817.241% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -4531.715% |
| Histogen Inc. | 3.76 Million USD | -3619.873% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -24233.063% |
| Surrozen, Inc. | -27.23 Million USD | 614.881% |
| Organovo Holdings, Inc. | -5.38 Million USD | 2701.633% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 11736.18% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 646.66% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 7081009.091% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -2211.115% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 208948.371% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 9.425% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -96060.494% |
| Apollomics, Inc. | 127 Thousand USD | -110295.276% |
| Amarin Corporation plc | 165.54 Million USD | 15.307% |
| Turnstone Biologics Corp. | 16.5 Million USD | -749.4% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 226.892% |
| Synaptogenix, Inc. | -6347.00 USD | 2209049.11% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 275005.882% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 13.115% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 92.023% |
| Better Therapeutics, Inc. | -2.72 Million USD | 5237.486% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 225.001% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 58.53% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1229079.663% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 2339.649% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 12753.61% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -1815.851% |
| Insmed Incorporated | 239.63 Million USD | 41.494% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -3818.446% |
| OmniAb, Inc. | 14.66 Million USD | -855.901% |
| Alector, Inc. | -95.05 Million USD | 247.499% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -11.607% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 422.578% |
| Zai Lab Limited | 170.9 Million USD | 17.964% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -71.235% |
| Aura Biosciences, Inc. | -1.29 Million USD | 10926.409% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -107747.692% |
| Immunic, Inc. | -111 Thousand USD | 126408.108% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -784.332% |
| Veracyte, Inc. | 248.14 Million USD | 43.501% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 102.006% |
| FibroGen, Inc. | 128.9 Million USD | -8.765% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 24858610.638% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 1301.709% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -35941.645% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 60.545% |
| Galecto, Inc. | -830 Thousand USD | 16991.807% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 10222.888% |
| Fortrea Holdings Inc. | 424 Million USD | 66.933% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 262.71% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 24826.984% |
| XBiotech Inc. | -1.74 Million USD | 8139.106% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 12753.61% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 401.698% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 285.614% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -91.003% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -734.387% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 63.962% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 382.398% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 57.092% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 1338.113% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -473.4% |
| NexImmune, Inc. | -1.02 Million USD | 13778.618% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -2596233.333% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 2073.104% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 98.759% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 209898.435% |
| Ainos, Inc. | -253.73 Thousand USD | 55355.722% |
| Pluri Inc. | 322 Thousand USD | -43440.994% |
| Prothena Corporation plc | -129.2 Million USD | 208.515% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -178.046% |
| Celularity Inc. | 6.75 Million USD | -1975.529% |
| Rallybio Corporation | -150 Thousand USD | 93568.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | 529.975% |
| MeiraGTx Holdings plc | 287 Thousand USD | -48750.871% |
| Omeros Corporation | -69.77 Million USD | 300.923% |
| Humacyte, Inc. | -76.55 Million USD | 283.151% |
| Immunocore Holdings plc | 248.39 Million USD | 43.556% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 1024.267% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -124.748% |
| Blueprint Medicines Corporation | 236.58 Million USD | 40.739% |
| CalciMedica, Inc. | -58 Thousand USD | 241827.586% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 9931.837% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 5029.747% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 554.243% |
| Pulmatrix, Inc. | -8.22 Million USD | 1805.62% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 12083.077% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 35238.346% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 135.156% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -4951.259% |
| Cytokinetics, Incorporated | -322.59 Million USD | 143.461% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -16162.752% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 41214.956% |
| Vor Biopharma Inc. | -3.49 Million USD | 4114.948% |
| Roivant Sciences Ltd. | 109.23 Million USD | -28.349% |
| Evogene Ltd. | 1.39 Million USD | -9921.587% |
| ProKidney Corp. | -3.16 Million USD | 4524.172% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 419.279% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -1944.655% |
| CorMedix Inc. | -205.56 Thousand USD | 68304.24% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 278.213% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 424954.545% |
| Atai Life Sciences N.V. | -5000.00 USD | 2804140.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 115152.643% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 146143.75% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 10193.737% |
| Sagimet Biosciences Inc. | 2 Million USD | -6910.1% |
| MediciNova, Inc. | 979.7 Thousand USD | -14210.634% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 266.276% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 148375.607% |
| GeoVax Labs, Inc. | -20.72 Million USD | 776.626% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 42.666% |
| Biomea Fusion, Inc. | -4.2 Million USD | 3437.348% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 83.928% |
| Mereo BioPharma Group plc | 7.42 Million USD | -1787.988% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 45326.452% |
| Absci Corporation | -41.84 Million USD | 435.019% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 2804140.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 283.575% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 5796.952% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 34.404% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 14999.256% |
| Allakos Inc. | -6.14 Million USD | 2383.048% |
| Imunon, Inc. | -720 Thousand USD | 19572.365% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 303.203% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 70.539% |
| BioAtla, Inc. | -103.73 Million USD | 235.159% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1229079.663% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 78865.169% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 157.739% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 45181.029% |
| XOMA Corporation | 3.86 Million USD | -3531.235% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 300.046% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -847.695% |
| aTyr Pharma, Inc. | -2.38 Million USD | 5971.106% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -1025.217% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 483555.172% |
| Viridian Therapeutics, Inc. | -1 Million USD | 14008.929% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -1078476823.077% |
| Akari Therapeutics, Plc | -4000.00 USD | 3505150.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 77.987% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -71906.286% |
| UroGen Pharma Ltd. | 73.35 Million USD | -91.136% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 625.219% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -1207496.899% |
| Orgenesis Inc. | -5.72 Million USD | 2548.943% |
| Entera Bio Ltd. | -56 Thousand USD | 250460.714% |
| GH Research PLC | -315 Thousand USD | 44608.571% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 74280.952% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 26805.143% |
| Xencor, Inc. | -85.26 Million USD | 264.441% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 63546.422% |
| Replimune Group, Inc. | -2.65 Million USD | 5380.678% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 14102.892% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 21.166% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -71906.286% |
| Portage Biotech Inc. | -54 Thousand USD | 259733.333% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 148375.607% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 37288.859% |
| OncoCyte Corporation | 413 Thousand USD | -33847.215% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 3119165.628% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 63154154.054% |
| Purple Biotech Ltd. | -196 Thousand USD | 71631.633% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -1463.359% |
| scPharmaceuticals Inc. | 9.78 Million USD | -1333.265% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 1442.294% |
| HilleVax, Inc. | -2.15 Million USD | 6602.876% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 144638.144% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 934530.818% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 21088.323% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 609673.913% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 1867925.892% |
| Savara Inc. | -44.26 Million USD | 416.755% |
| Curis, Inc. | 9.81 Million USD | -1329.029% |
| Daré Bioscience, Inc. | 2.76 Million USD | -4962.318% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 112452.149% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 61592.105% |
| BeiGene, Ltd. | 2.07 Billion USD | 93.256% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 5114.557% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 135.08% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -147.322% |
| Erasca, Inc. | -3.73 Million USD | 3856.752% |
| bluebird bio, Inc. | -4.03 Million USD | 3578.958% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 496953.073% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 92.638% |
| DBV Technologies S.A. | 15.72 Million USD | -791.417% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 496953.073% |
| Moderna, Inc. | 2.15 Billion USD | 93.494% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 15422.623% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -1651.212% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 26257.09% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -4.794% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 2353.327% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 456.358% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 226.163% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 4007.525% |
| MacroGenics, Inc. | 50.52 Million USD | -177.479% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 2399.147% |
| Prime Medicine, Inc. | -147.9 Million USD | 194.792% |
| Aditxt, Inc. | -111.66 Thousand USD | 125661.526% |
| Adagene Inc. | 18.11 Million USD | -674.105% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -28629.918% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 11.172% |
| SciSparc Ltd. | 2.19 Million USD | -6284.426% |
| Vericel Corporation | 135.57 Million USD | -3.412% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 559810.967% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 452627.274% |
| Generation Bio Co. | -73.91 Million USD | 289.69% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 32182.838% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -156.691% |
| Invivyd, Inc. | -2.02 Million USD | 7013.314% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 146.603% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 135642.064% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -45.486% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -42.644% |
| Clene Inc. | 533 Thousand USD | -26204.315% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -481.529% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 14750.157% |
| GeoVax Labs, Inc. | -20.72 Million USD | 776.626% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -6952.414% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 72251.547% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -181.502% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 2076.904% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 16870.574% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -68.078% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -191663.322% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -163.726% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 180.954% |
| Trevena, Inc. | 1.45 Million USD | -9535.876% |
| Surrozen, Inc. | -27.23 Million USD | 614.881% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 39817.28% |
| Cingulate Inc. | -582.91 Thousand USD | 24151.753% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 452364.516% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 811.721% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 1852173.976% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 16013.961% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 79.403% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 14290.486% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 248941.007% |
| Kronos Bio, Inc. | 1.37 Million USD | -10118.805% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 361.249% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 48114.384% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 28811.444% |
| ImmunityBio, Inc. | -17.89 Million USD | 883.689% |
| Korro Bio, Inc. | -3.63 Million USD | 3962.314% |
| Kineta, Inc. | 5.43 Million USD | -2480.563% |
| BioVie Inc. | -229.37 Thousand USD | 61222.955% |
| Codexis, Inc. | 57.33 Million USD | -144.536% |
| Celularity Inc. | 6.75 Million USD | -1975.529% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -3393.695% |
| Celcuity Inc. | -142.77 Thousand USD | 98299.927% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -277033.821% |
| Cibus, Inc. | 1.42 Million USD | -9759.494% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 37587.166% |
| IN8bio, Inc. | -2.5 Million USD | 5705.838% |
| Kodiak Sciences Inc. | -25.94 Million USD | 640.34% |
| Annexon, Inc. | -3.26 Million USD | 4391.46% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 6959.198% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 435.918% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -21806.563% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 81.991% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 18.937% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 7479.053% |
| Arcellx, Inc. | 108.27 Million USD | -29.482% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 533.137% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -77.014% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 762.831% |
| Moolec Science SA | -143.3 Thousand USD | 97934.688% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 431.306% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -4165.348% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 300.031% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 3881661.462% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -60490.948% |
| Humacyte, Inc. | -76.55 Million USD | 283.151% |
| 89bio, Inc. | -273 Thousand USD | 51456.044% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 11253.699% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 16633.255% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 114085.366% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -12429.223% |
| Notable Labs, Ltd. | 113 Thousand USD | -123972.566% |
| Liquidia Corporation | 14.6 Million USD | -860.288% |
| Mustang Bio, Inc. | -2.22 Million USD | 6401.213% |
| Immunovant, Inc. | -231 Thousand USD | 60793.506% |
| Quantum-Si incorporated | 488 Thousand USD | -28629.918% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 352.348% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 467440.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -7429.646% |
| Acasti Pharma Inc. | -11 Thousand USD | 1274663.636% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 68619.233% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 21720.963% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 183.697% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -12257.172% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 36898.425% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 7260.47% |
| PepGen Inc. | -1.18 Million USD | 11941.385% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 110495.276% |
| United Therapeutics Corporation | 2.07 Billion USD | 93.227% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 712.316% |
| Solid Biosciences Inc. | -76.56 Million USD | 283.12% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 169871.018% |
| Immuneering Corporation | -764.13 Thousand USD | 18447.733% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -211480.949% |
| Belite Bio, Inc | -399 Thousand USD | 35238.346% |
| XOMA Corporation | 3.86 Million USD | -3531.235% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 799.75% |
| Bionomics Limited | -434.44 Thousand USD | 32371.222% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 13154.19% |
| uniQure N.V. | 2.21 Million USD | -6229.661% |
| Cassava Sciences, Inc. | -89.42 Million USD | 256.785% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 252.279% |
| Forte Biosciences, Inc. | -9000.00 USD | 1557900.0% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 16890.659% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 32182.838% |
| Altimmune, Inc. | -65.37 Million USD | 314.465% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 61.273% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 13154.19% |
| Compugen Ltd. | 31.45 Million USD | -345.722% |
| Peak Bio, Inc. | 367.76 Thousand USD | -38022.3% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -471.88% |
| Benitec Biopharma Inc. | 108 Thousand USD | -129716.667% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 179846.154% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 11754.364% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 7794.951% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 117916.807% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 11754.364% |
| Instil Bio, Inc. | -4.75 Million USD | 3047.897% |
| argenx SE | 1.1 Billion USD | 87.352% |
| Immunome, Inc. | -8.9 Million USD | 1674.065% |
| Verona Pharma plc | -679.62 Thousand USD | 20729.348% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 80215.429% |
| Shattuck Labs, Inc. | -2.38 Million USD | 5978.491% |
| CervoMed Inc. | -1.29 Million USD | 10937.9% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 5924.761% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 3034.938% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -5573.897% |
| Moolec Science SA | -143.3 Thousand USD | 97934.688% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 34460.709% |
| Design Therapeutics, Inc. | -537 Thousand USD | 26208.38% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 32934.192% |
| NeurAxis, Inc. | 2.15 Million USD | -6400.753% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -6433.178% |
| Lumos Pharma, Inc. | 2 Million USD | -6885.65% |
| Achilles Therapeutics plc | -4.73 Million USD | 3063.308% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 80215.429% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 132772.818% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -342.854% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -16162.752% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 13685.465% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 407.812% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -325951.163% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 17156.204% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 1065626.676% |
| Palisade Bio, Inc. | 246 Thousand USD | -56892.683% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 424954.545% |
| Beam Therapeutics Inc. | -59.67 Million USD | 334.954% |
| Neurogene Inc. | -3.26 Million USD | 4398.038% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -0.622% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -250.505% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 47306.061% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 3581.518% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 1565.628% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -895.753% |
| Athira Pharma, Inc. | -969 Thousand USD | 14568.731% |
| Vaccinex, Inc. | -16 Million USD | 976.043% |
| HCW Biologics Inc. | -574.82 Thousand USD | 24490.422% |
| XOMA Corporation | 3.86 Million USD | -3531.235% |
| Nektar Therapeutics | 53.47 Million USD | -162.168% |
| Arvinas, Inc. | 71.8 Million USD | -95.267% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 267.985% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 323.341% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 43640.994% |
| Rezolute, Inc. | -36 Thousand USD | 389550.0% |
| Clene Inc. | 533 Thousand USD | -26204.315% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 10919258.879% |
| BeyondSpring Inc. | 1.75 Million USD | -7906.967% |
| Synlogic, Inc. | -1.92 Million USD | 7387.006% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 379024.324% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 2314.182% |
| Peak Bio, Inc. | 367.76 Thousand USD | -38022.3% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 839.345% |
| Krystal Biotech, Inc. | 47.6 Million USD | -194.511% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 0.63% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -2690.09% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 5514.837% |
| MannKind Corporation | 136.19 Million USD | -2.945% |
| Ikena Oncology, Inc. | -50.49 Million USD | 377.672% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -28.846% |
| Gossamer Bio, Inc. | -4.38 Million USD | 3297.309% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 55735.714% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 2804140.0% |
| Legend Biotech Corporation | 140.92 Million USD | 0.516% |
| Mural Oncology plc | -2.56 Million USD | 5561.706% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 25545.009% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 140302.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -575.542% |
| REGENXBIO Inc. | 53.02 Million USD | -164.387% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 2717.197% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 72979.532% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 8194.804% |
| Vaxart, Inc. | -60.76 Million USD | 330.736% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 53453.375% |
| Cellectis S.A. | 18 Thousand USD | -778800.0% |
| Longeveron Inc. | 221 Thousand USD | -63339.819% |
| Repare Therapeutics Inc. | -80.07 Million USD | 275.099% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 87.173% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 10934.776% |
| Revolution Medicines, Inc. | -399.66 Million USD | 135.08% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 400677.143% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -286026.531% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 98.371% |
| Denali Therapeutics Inc. | -93.34 Million USD | 250.198% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 559810.967% |
| Veru Inc. | 7.56 Million USD | -1753.071% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 92949.007% |
| Cingulate Inc. | -582.91 Thousand USD | 24151.753% |
| Passage Bio, Inc. | -3.72 Million USD | 3867.858% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 1164181.7% |
| Exicure, Inc. | -1.42 Million USD | 9952.565% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 36706.266% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -5086.903% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 27447.15% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -105.798% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 93813.529% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 336.804% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -35757.289% |
| OmniAb, Inc. | 14.66 Million USD | -855.901% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -601.255% |
| Lipocine Inc. | -2.85 Million USD | 5017.957% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 7707.271% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 2557.528% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 9407.763% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -86.152% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 215795.385% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -66.321% |
| Ocugen, Inc. | -33.53 Million USD | 518.052% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 4533.966% |
| Q32 Bio Inc. | 578 Thousand USD | -24156.401% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 53006.415% |
| Alumis Inc. Common Stock | -1.28 Million USD | 11019.159% |
| Equillium, Inc. | 35.95 Million USD | -289.905% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 8313.357% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -27902.373% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 3391536.865% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 54232.046% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -33067.263% |
| Dominari Holdings Inc. | 2.03 Million USD | -6776.018% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 76516.436% |
| vTv Therapeutics Inc. | -13.59 Million USD | 1131.276% |
| Bio-Techne Corporation | 773.07 Million USD | 81.864% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -709.527% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 69.573% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 12093.328% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 684.662% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -1098.615% |
| Nkarta, Inc. | -5.86 Million USD | 2488.857% |
| BioCardia, Inc. | -7.24 Million USD | 2034.087% |
| Iterum Therapeutics plc | -1.75 Million USD | 8111.543% |